Position in NVS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$10,065,183
-$452,263 QoQ
Shares Held
64,224
-6.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#174
of 1,603 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empowered Funds, LLC holds $505,465,921 across 15 Drug Manufacturers - General names. NVS ranks #9 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
138,183 | $165,740,842 | |
| 2 | JNJ |
Johnson & Johnson
|
348,850 | $88,597,425 | |
| 3 | MRK |
Merck & Co., Inc.
|
576,918 | $74,133,959 | |
| 4 | ABBV |
AbbVie Inc.
|
202,359 | $50,921,611 | |
| 5 | AMGN |
Amgen Inc
|
95,907 | $34,729,836 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
225,845 | $28,533,251 | |
| 7 | PFE |
Pfizer Inc
|
1,018,817 | $24,533,110 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
239,727 | $13,813,066 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,065,183 | 64,224 | Shares | Other | 2026-08-17 | |
| 2026-03-31 | $10,517,446 | 68,854 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $8,344,579 | 60,525 | Shares | Other | 2026-02-18 | |
| 2025-09-30 | $8,640,423 | 67,377 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $7,845,681 | 64,835 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $1,764,170 | 15,825 | Shares | Sole | 2025-05-16 | |
| No filing history on record for this holder in this stock. | ||||||